George Sellers
Stock Analyst at Stephens & Co.
(1.30)
# 3,607
Out of 4,984 analysts
43
Total ratings
27.27%
Success rate
-7.09%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $39.10 | +73.91% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $125.62 | +130.85% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $30.02 | +93.20% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $119.81 | +48.57% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $8.66 | +177.14% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $32.13 | +124.09% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $2.20 | +127.27% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $7.04 | +255.11% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $27.16 | +109.87% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $82.10 | -13.52% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $39.10
Upside: +73.91%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $125.62
Upside: +130.85%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $30.02
Upside: +93.20%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $119.81
Upside: +48.57%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $8.66
Upside: +177.14%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $32.13
Upside: +124.09%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $2.20
Upside: +127.27%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $7.04
Upside: +255.11%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $27.16
Upside: +109.87%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $82.10
Upside: -13.52%